var data={"title":"Gianotti-Crosti syndrome (papular acrodermatitis)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Gianotti-Crosti syndrome (papular acrodermatitis)</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/contributors\" class=\"contributor contributor_credentials\">Antonio A T Chuh, MD, FRCP, FRCPCH</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/contributors\" class=\"contributor contributor_credentials\">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/contributors\" class=\"contributor contributor_credentials\">Abena O Ofori, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 20, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gianotti-Crosti syndrome (GCS), also known as papular acrodermatitis, papular acrodermatitis of childhood, and infantile papular acrodermatitis, is a symmetric papular eruption with an acral distribution (cheeks, buttocks, and extensor surfaces of the forearms and legs) (<a href=\"image.htm?imageKey=PEDS%2F67780%7EDERM%2F95217%7EDERM%2F95218%7EDERM%2F95219%7EDERM%2F95220%7EDERM%2F95221\" class=\"graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221 \">picture 1A-F</a>). It was first described by Gianotti in 1955, and by Crosti and Gianotti in 1957 [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/1,2\" class=\"abstract_t\">1,2</a>], and was initially believed to occur only in infants and children [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/3-5\" class=\"abstract_t\">3-5</a>]. It has since been reported in adults [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/6-8\" class=\"abstract_t\">6-8</a>].</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">TERMINOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the original descriptions, Gianotti-Crosti syndrome (GCS) had three cardinal manifestations [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/1-5\" class=\"abstract_t\">1-5</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonrelapsing erythemato-papular dermatitis localized to the face and limbs, lasting about three weeks</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Paracortical hyperplasia of lymph nodes</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute hepatitis, usually anicteric, which could last for months and progress to chronic liver disease</p><p/><p>Gianotti referred to papular or papulovesicular acral eruptions, with or without itching, associated with reactive lymphadenitis, but not hepatitis, as &quot;papulovesicular acrolocated syndrome&quot; [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/4\" class=\"abstract_t\">4</a>]. However, it is not possible to distinguish between GCS and papulovesicular acrolocated syndrome solely on the basis of cutaneous findings [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/9\" class=\"abstract_t\">9</a>].</p><p>With current terminology, neither lymphadenopathy nor hepatitis is mandatory for the diagnosis of GCS. The term &quot;Gianotti-Crosti disease&quot; is sometimes reserved for patients with GCS that is documented to be related to hepatitis B virus (HBV) infection [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence and prevalence of Gianotti-Crosti syndrome (GCS) are unknown. Because many children with GCS may be diagnosed with a &quot;viral rash&quot; or &quot;nonspecific viral exanthem,&quot; GCS is probably underdiagnosed [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/11\" class=\"abstract_t\">11</a>]. (See <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> below.)</p><p>GCS primarily affects children younger than five years of age. During childhood, boys and girls are equally affected [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/12,13\" class=\"abstract_t\">12,13</a>]. However, in adulthood, females may be more prone than males to develop GCS [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>].</p><p>Most reports of GCS describe isolated cases. However, several outbreaks have been described [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/14-18\" class=\"abstract_t\">14-18</a>]. Three outbreaks in Japan were associated with HBV and involved 153, 54, and 14 patients [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/14-16\" class=\"abstract_t\">14-16</a>]. The remaining two outbreaks were associated with Epstein-Barr virus (EBV) infection, and each involved five patients [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/17,18\" class=\"abstract_t\">17,18</a>]. A mini-epidemic with four patients was reported, but the underlying virological cause was not found [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Overall, the epidemiologic features (eg, young age of onset, equal sex distribution in children, and occurrences of outbreaks) support GCS being an infectious disease [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/20\" class=\"abstract_t\">20</a>]. (See <a href=\"#H4\" class=\"local\">'Etiology'</a> below.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gianotti-Crosti syndrome (GCS) usually occurs in association with a viral illness. HBV and EBV are the most common causes. In a review of 308 cases, 22 percent were caused by HBV and 78 percent by other viruses [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/9\" class=\"abstract_t\">9</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Hepatitis B virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The association of GCS with HBV infection is well known [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/9,14-16,21-24\" class=\"abstract_t\">9,14-16,21-24</a>]. However, HBV is an uncommon cause of GCS in the United States and in other countries where universal hepatitis B vaccination during infancy is routine [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. In infants and young children with acute HBV infection, GCS may be the only clinical manifestation. This might result in chronic hepatitis decades later [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/25\" class=\"abstract_t\">25</a>]. The clinical manifestations, treatment, and prevention of hepatitis B virus are discussed separately. (See <a href=\"topic.htm?path=overview-of-hepatitis-b-virus-infection-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Overview of hepatitis B virus infection in children and adolescents&quot;</a> and <a href=\"topic.htm?path=epidemiology-transmission-and-prevention-of-hepatitis-b-virus-infection\" class=\"medical medical_review\">&quot;Epidemiology, transmission, and prevention of hepatitis B virus infection&quot;</a> and <a href=\"#H15\" class=\"local\">'Complications'</a> below.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Epstein-Barr virus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Epstein-Barr virus is another common cause of GCS, accounting for approximately one-half to three-quarters of cases in some series [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/12,26-35\" class=\"abstract_t\">12,26-35</a>]. The clinical manifestations and treatment of EBV infection are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of Epstein-Barr virus infection&quot;</a> and <a href=\"#H15\" class=\"local\">'Complications'</a> below.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Other infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>GCS is less commonly reported in association with other pathogens, including enteroviruses [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/36,37\" class=\"abstract_t\">36,37</a>], cytomegalovirus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/38-41\" class=\"abstract_t\">38-41</a>], parvovirus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/42,43\" class=\"abstract_t\">42,43</a>], parainfluenza virus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/44,45\" class=\"abstract_t\">44,45</a>], hepatitis A virus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/46,47\" class=\"abstract_t\">46,47</a>], rotavirus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/48,49\" class=\"abstract_t\">48,49</a>], molluscum contagiosum [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/42,50\" class=\"abstract_t\">42,50</a>], respiratory syncytial virus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/37\" class=\"abstract_t\">37</a>], human immunodeficiency virus [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/51\" class=\"abstract_t\">51</a>], human herpesvirus 6 (mainly 6B) [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/52-54\" class=\"abstract_t\">52-54</a>], <em>Mycoplasma pneumoniae</em> [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/55,56\" class=\"abstract_t\">55,56</a>], beta-hemolytic streptococci [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/37\" class=\"abstract_t\">37</a>], <em>Bartonella henselae</em> [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/57\" class=\"abstract_t\">57</a>], and <em>Borrelia burgdorferi</em> [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/58\" class=\"abstract_t\">58</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Vaccines</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>GCS has been reported to occur after the administration of various vaccines, including influenza virus vaccine [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/59-62\" class=\"abstract_t\">59-62</a>], measles-mumps-rubella vaccines [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/63\" class=\"abstract_t\">63</a>], hepatitis B and measles vaccines [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/64,65\" class=\"abstract_t\">64,65</a>], oral polio vaccine [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/66,67\" class=\"abstract_t\">66,67</a>], <a href=\"topic.htm?path=hepatitis-a-vaccine-drug-information\" class=\"drug drug_general\">hepatitis A vaccine</a>&nbsp;[<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/68\" class=\"abstract_t\">68</a>], and Japanese encephalitis vaccine [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/69\" class=\"abstract_t\">69</a>]. One of the largest studies, a study of 116 children diagnosed with GCS in close proximity to scheduled national days for receipt of the oral polio vaccine, found that GCS was more often present one month after scheduled vaccination days (105 children, 90 percent) than one month prior to these days (11 children, 10 percent) [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/67\" class=\"abstract_t\">67</a>]. Additional study is necessary to clarify the relationship between GCS and vaccines. </p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of Gianotti-Crosti syndrome (GCS), including the mechanism for the acral distribution of lesions, is unknown. Lesional histopathologic changes are nonspecific, and include focal spongiosis (collections of fluid in the epidermis) and parakeratosis with perivascular lymphocytic infiltrates in the upper dermis [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/70\" class=\"abstract_t\">70</a>].</p><p>The clinical manifestations of GCS may represent a final common pathway for infections caused by several viruses. One hypothesis suggests that the clinical manifestations result from a delayed hypersensitivity reaction to viral infections [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/71\" class=\"abstract_t\">71</a>].</p><p>The significance of immunoglobulin E (IgE)-mediated immunity in the pathogenesis of GCS and other viral exanthems is another area of investigation. GCS appears to be associated with atopy, which is characterized by the production of specific IgE following allergen exposure. A case-control study noted that children with GCS were significantly more likely to have had atopic dermatitis and to have a family history of atopy than control children who were being evaluated for recurrent infections (24 versus 7 percent for atopic dermatitis and 52 versus 31 percent for family history of atopy) [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/72\" class=\"abstract_t\">72</a>]. In another case-control study with 37 children with GCS and matched controls, atopic dermatitis was more common among children with GCS than without GCS (76 versus 24 percent), and children with GCS were more likely to have at least one atopic disorder (84 versus 51 percent) [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/73\" class=\"abstract_t\">73</a>]. (See <a href=\"topic.htm?path=the-relationship-between-ige-and-allergic-disease\" class=\"medical medical_review\">&quot;The relationship between IgE and allergic disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gianotti-Crosti syndrome (GCS) usually occurs in children younger than five years, but older children, adolescents, and adults also may be affected [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/74\" class=\"abstract_t\">74</a>]. Most patients have an upper respiratory or gastrointestinal illness in the week before the onset of the rash [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]; the initial illness may have resolved by the time the child presents with the rash.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Dermatologic findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>GCS presents as a sudden symmetric eruption of multiple small papular or papulovesicular lesions. The lesions are monomorphous, flat-topped, pink-brown papules or papulovesicles, 1 to 10 mm in diameter; they may coalesce into plaques (<a href=\"image.htm?imageKey=PEDS%2F67780%7EDERM%2F95217%7EDERM%2F95218%7EDERM%2F95219%7EDERM%2F95220%7EDERM%2F95221\" class=\"graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221 \">picture 1A-F</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10,75\" class=\"abstract_t\">10,75</a>].</p><p>The face, buttocks, extensor aspects of forearms and legs, and feet are predominantly affected. Truncal lesions are commonly present, although more transient and fewer in number than acrally-distributed lesions. The presence of truncal lesions does not exclude a diagnosis of GCS [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/76\" class=\"abstract_t\">76</a>]. The mucosal surfaces and nails are not involved [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/77,78\" class=\"abstract_t\">77,78</a>].</p><p>The appearance of lesions at sites of trauma (ie, the Koebner phenomenon) may be seen during the early phase [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/12,78\" class=\"abstract_t\">12,78</a>]. Pruritus usually is of mild to moderate severity; however, the spectrum ranges from absent to severe.</p><p>Hemorrhagic changes occasionally occur, particularly in areas subject to trauma [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10,75,78,79\" class=\"abstract_t\">10,75,78,79</a>]. It has been suggested that patients with petechial lesions are more likely to have HBV [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/80\" class=\"abstract_t\">80</a>]. However, the cutaneous findings of GCS are not helpful in determining whether GCS is caused by HBV, EBV, or another etiologic agent [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/9\" class=\"abstract_t\">9</a>]. (See <a href=\"topic.htm?path=overview-of-hepatitis-b-virus-infection-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Overview of hepatitis B virus infection in children and adolescents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Other findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Affected patients may have concurrent malaise, low-grade fever, or diarrhea [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. Lymphadenopathy is present in 25 to 35 percent of patients, usually in the cervical, axillary, or inguinal regions [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/12,81\" class=\"abstract_t\">12,81</a>]. The frequency of hepatic involvement is not known [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. When hepatitis is present, it usually is anicteric (without clinically recognized jaundice) [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/5,82\" class=\"abstract_t\">5,82</a>]. Splenomegaly may occur, but is uncommon [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>].</p><p>Neither lymphadenopathy nor hepatomegaly is necessary to make a diagnosis of GCS. (See <a href=\"#H16\" class=\"local\">'Diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Laboratory findings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are no laboratory features characteristic of GCS. Patients with GCS may have modest lymphocytosis or lymphopenia [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. Liver enzymes may be elevated in patients with EBV, CMV, or hepatitis-associated disease. Skin biopsy may be useful in cases that are clinically confusing.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Course</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most children with GCS have an excellent prognosis, although the course may be prolonged [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. Spontaneous remission of the rash without active intervention is the rule. The rash usually lasts from 10 days to 6 months; however, durations ranging from 5 days to 12 months have been reported [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/81\" class=\"abstract_t\">81</a>]. Pruritus may last for weeks.</p><p>In the initial two to three weeks, new papules and papulovesicles continue to occur, and the areas of involvement expand. The distribution of eruption is most classic in the middle phase of the disease. Near the end of the course, slow resolution of the lesions occurs. There may be mild postinflammatory hyperpigmentation or hypopigmentation. However, scarring <span class=\"nowrap\">and/or</span> pigment changes usually are not permanent. Recurrences are possible, but rare [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/83\" class=\"abstract_t\">83</a>].</p><p>Lymphadenopathy and hepatomegaly (or hepatosplenomegaly) usually take longer to resolve than the cutaneous lesions [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/22,78\" class=\"abstract_t\">22,78</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h3\">Complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Postinflammatory hypopigmentation or hyperpigmentation occurs frequently in children with darker skin types and can persist for months after resolution of the rash, but eventually resolves [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10,84\" class=\"abstract_t\">10,84</a>]. Permanent scarring is infrequent, even for children with facial involvement.</p><p>Other potential complications are related to the underlying etiology. Complications related to EBV infection, including splenic rupture, or lymphoproliferative disorders, are theoretically possible [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/85\" class=\"abstract_t\">85</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection#H7\" class=\"medical medical_review\">&quot;Clinical manifestations and treatment of Epstein-Barr virus infection&quot;, section on 'Complications'</a>.)</p><p>Children with acute HBV infection may progress to chronic infection [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/14\" class=\"abstract_t\">14</a>]. The age at the time of acute infection is the main determinant of the risk of progression: more than 90 percent of infants infected perinatally, and 25 to 50 percent of children infected between one and five years of age, develop chronic HBV infection [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/86\" class=\"abstract_t\">86</a>]. The natural history of chronic HBV infection in children is variable, depending upon age, mode of acquisition, and ethnicity. (See <a href=\"topic.htm?path=overview-of-hepatitis-b-virus-infection-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Overview of hepatitis B virus infection in children and adolescents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gianotti-Crosti syndrome (GCS) is a clinical diagnosis. Laboratory investigations are not helpful in establishing the diagnosis in young children, but may be necessary to determine the etiology or to exclude other conditions in the differential diagnosis, particularly if the eruption or course is atypical for GCS. (See <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Clinical diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A diagnosis of GCS is strongly suggested by the sudden onset of a symmetrically distributed papular or papulovesicular eruption in a young child that primarily involves the face, buttocks, <span class=\"nowrap\">and/or</span> extensor surfaces of the extremities and does not have another identifiable cause (<a href=\"image.htm?imageKey=PEDS%2F67780%7EDERM%2F95217%7EDERM%2F95218%7EDERM%2F95219%7EDERM%2F95220%7EDERM%2F95221\" class=\"graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221 \">picture 1A-F</a>). The presence of extracutaneous signs and symptoms (eg, malaise, fever, diarrhea, lymphadenopathy) is variable.</p><p>The establishment of diagnostic criteria would help to facilitate the clinical diagnosis of GCS and future studies of the disease. It remains to be determined whether diagnostic criteria proposed by the author and others are the ideal criteria for the diagnosis of this disease [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/87\" class=\"abstract_t\">87</a>]. More studies are necessary to assess the criteria-rated validity, test-test intra-clinician reliability, and inter-clinician reliability [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/88\" class=\"abstract_t\">88</a>].</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Skin biopsy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lesional histopathologic changes are nonspecific and cannot confirm the diagnosis. However, lesional skin biopsy may be necessary to exclude other considerations in the differential diagnosis if the rash is atypical (eg, more prominent truncal than acral distribution or lack of spontaneous resolution in six months). (See <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Etiologic diagnosis</span></p><p class=\"headingAnchor\" id=\"H26396446\"><span class=\"h3\">HBV</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Whether HBV serology and liver function tests are indicated for children with a diagnosis of GCS is controversial. On the one hand, HBV is an uncommon cause of GCS in countries where universal hepatitis B vaccination during infancy is routine [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]; HBV also appears to be an uncommon cause of GCS in some developing countries, such as India [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/89\" class=\"abstract_t\">89</a>].</p><p>On the other hand, GCS may be the only clinical manifestation of acute HBV in infants and young children. The presence of jaundice cannot be used to indicate the need for HBV testing, since the hepatitis associated with GCS is usually anicteric. (See <a href=\"topic.htm?path=overview-of-hepatitis-b-virus-infection-in-children-and-adolescents#H5\" class=\"medical medical_review\">&quot;Overview of hepatitis B virus infection in children and adolescents&quot;, section on 'Acute HBV infection'</a> and <a href=\"#H12\" class=\"local\">'Other findings'</a> above.)</p><p>The ethnic origin, HBV carrier status of parents and family members (if known), physical status of the child, immunization status of the child, and local prevalence of HBV infection are factors to consider in making a decision about testing for HBV. (See <a href=\"topic.htm?path=epidemiology-transmission-and-prevention-of-hepatitis-b-virus-infection\" class=\"medical medical_review\">&quot;Epidemiology, transmission, and prevention of hepatitis B virus infection&quot;</a>.)</p><p>We suggest the following tests for patients who are at increased risk for hepatitis B virus or who have hepatomegaly [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Liver function tests</strong> &ndash; Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase, and gamma-glutamyl transpeptidase (GGT).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatitis B serology</strong> &ndash; Hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBsAb), and hepatitis B core antibody (HBcAb). (See <a href=\"topic.htm?path=hepatitis-b-virus-screening-and-diagnosis\" class=\"medical medical_review\">&quot;Hepatitis B virus: Screening and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H26396461\"><span class=\"h3\">Other viruses</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Investigations for EBV such as polymerase chain reaction for EBV DNA in peripheral blood mononuclear cells and serologic testing are generally unnecessary, since they do not affect clinical management.</p><p>However, identification of an etiologic agent may be indicated in immunocompromised patients <span class=\"nowrap\">and/or</span> patients with close contact with immunocompromised patients or pregnant women [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/90\" class=\"abstract_t\">90</a>]. (See <a href=\"#H7\" class=\"local\">'Other infections'</a> above.)</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The constellation of clinical features in Gianotti-Crosti syndrome (GCS) is usually so characteristic that the diagnosis can be made relatively easily [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. However, early in the course, during resolution, or in atypical cases, a number of other conditions may warrant consideration.</p><p>Common conditions in the differential diagnosis of GCS include erythema infectiosum or other viral exanthems, erythema multiforme (early in the course), hand-foot-mouth disease, papular urticaria, scabies, diffuse lichen planus, and cutaneous drug eruptions. Less common, but important, conditions to consider in the differential diagnosis of GCS (because of the different implications for treatment, prognosis, and spread of infection) include papular purpuric gloves and socks syndrome, acrodermatitis enteropathica, immunoglobulin A vasculitis (IgAV; Henoch-Sch&ouml;nlein purpura [HSP]), and Kawasaki disease.</p><p>Clinical features that may help to differentiate these conditions from GCS include the onset, duration, distribution, and color of the rash; the presence and intensity of pruritus; and the involvement of the mucosa or nails [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/78\" class=\"abstract_t\">78</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Erythema infectiosum </strong>&minus; Erythema infectiosum (EI, also known as &quot;fifth disease&quot;) is a common childhood exanthem caused by parvovirus B19. Like GCS, EI begins with nonspecific prodromal illness and acral eruption. However, the rash of EI, which begins on the cheeks (<a href=\"image.htm?imageKey=PEDS%2F71737\" class=\"graphic graphic_picture graphicRef71737 \">picture 2</a>) and spreads to the extremities (<a href=\"image.htm?imageKey=ID%2F75125\" class=\"graphic graphic_picture graphicRef75125 \">picture 3</a>), is usually macular rather than papular. By the time the rash develops, the child is no longer contagious. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-parvovirus-b19-infection#H525137743\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of parvovirus B19 infection&quot;, section on 'Erythema infectiosum'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Erythema multiforme </strong>&minus; Erythema multiforme (EM) typically affects adolescents and young adults, but 20 percent of cases occur in children [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/75\" class=\"abstract_t\">75</a>]. EM is often caused by herpes simplex virus or Mycoplasma infection. Although target lesions are characteristic of EM (<a href=\"image.htm?imageKey=ID%2F74095\" class=\"graphic graphic_picture graphicRef74095 \">picture 4</a>), the lesions may be papular early in the course. Mucosal lesions are present in 25 to 50 percent of children with EM [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/75\" class=\"abstract_t\">75</a>] and may help to distinguish it from GCS.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hand, foot, and mouth disease </strong>&minus; Hand, foot, and mouth disease (HFM) is a common childhood illness that is usually caused by the group A coxsackieviruses. HFM is characterized by fever; oral vesicles on the buccal mucosa and tongue; and peripherally distributed small, tender cutaneous lesions on the hands, feet, buttocks, and (less commonly) genitalia (<a href=\"image.htm?imageKey=DERM%2F58566%7EDERM%2F71314%7EDERM%2F53423\" class=\"graphic graphic_picture graphicRef58566 graphicRef71314 graphicRef53423 \">picture 5A-C</a>). It usually resolves in around seven to ten days. The mucosal lesions and clinical course of HFM distinguish it from GCS. (See <a href=\"topic.htm?path=hand-foot-and-mouth-disease-and-herpangina#H4639421\" class=\"medical medical_review\">&quot;Hand, foot, and mouth disease and herpangina&quot;, section on 'Hand, foot, and mouth disease'</a> and <a href=\"topic.htm?path=hand-foot-and-mouth-disease-and-herpangina\" class=\"medical medical_review\">&quot;Hand, foot, and mouth disease and herpangina&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Scabies </strong>&minus; Scabies is an infestation of the skin by the mite Sarcoptes scabiei that results in an intensely pruritic eruption (<a href=\"image.htm?imageKey=DERM%2F56862%7EDERM%2F54315\" class=\"graphic graphic_picture graphicRef56862 graphicRef54315 \">picture 6A-B</a>). The degree of pruritus distinguishes scabies from GCS: GCS never itches as severely as virtually every case of scabies does. (See <a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Scabies: Epidemiology, clinical features, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Papular urticaria </strong>&minus; Papular urticaria (also known as insect bite-induced hypersensitivity reaction) is defined by chronic or recurrent eruptions of papules, vesicles, target lesions, or wheals caused by hypersensitivity to insect bites (eg, fleas, mosquitoes, bedbugs, mites) in children between 2 and 10 years of age. The lesions are symmetric and usually grouped in crops or clusters on exposed areas; they may take weeks to years to resolve. Management is reviewed separately. (See <a href=\"topic.htm?path=insect-bites#H4\" class=\"medical medical_review\">&quot;Insect bites&quot;, section on 'Papular urticaria'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lichen planus </strong>&minus; Diffuse lichen planus might mimic GCS in adults. Distinguishing features of lichen planus include intense pruritus, pale violet color (<a href=\"image.htm?imageKey=PC%2F59807\" class=\"graphic graphic_picture graphicRef59807 \">picture 7</a>), frequent involvement of the mucosal surfaces, and tendency to occur on the volar surface of the wrists (<a href=\"image.htm?imageKey=PC%2F50579\" class=\"graphic graphic_picture graphicRef50579 \">picture 8</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"topic.htm?path=lichen-planus\" class=\"medical medical_review\">&quot;Lichen planus&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Cutaneous drug eruption </strong>&minus; Cutaneous drug eruptions begin in dependent areas and generalize, often with associated mucus membrane erythema. Pruritus is the most common symptom. Blood eosinophilia may be present but is not a reliable finding. The most commonly prescribed medications (eg, antibiotics) are implicated most often.</p><p/><p class=\"bulletIndent1\">The clinical course distinguishes drug eruption from GCS. The onset of drug eruptions is almost always within two weeks of beginning a new drug, and within days of reexposure to a drug to which an individual is sensitized; chemically related compounds can cause cross reactions. Discontinuing the offending drug leads to resolution of the rash. (See <a href=\"topic.htm?path=drug-eruptions#H3\" class=\"medical medical_review\">&quot;Drug eruptions&quot;, section on 'Drug-induced exanthems'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Papular purpuric gloves and socks syndrome </strong>&minus; Papular purpuric gloves and socks syndrome (PPGSS) typically occurs in young adults, but may occur in children [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/75,91,92\" class=\"abstract_t\">75,91,92</a>]. It may be caused by several viruses including parvovirus B19, EBV, and CMV [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/93,94\" class=\"abstract_t\">93,94</a>]. It is characterized by rapidly progressive symmetric painful swelling and erythema of hands and feet, often with a petechial or purpuric component [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/75\" class=\"abstract_t\">75</a>]. There is a sharp demarcation at the wrists and ankles (<a href=\"image.htm?imageKey=ID%2F51856\" class=\"graphic graphic_picture graphicRef51856 \">picture 9</a>).</p><p/><p class=\"bulletIndent1\">Systemic features may include anorexia, fever, and arthralgias [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/90\" class=\"abstract_t\">90</a>]. Mucosal lesions, which do not occur in GCS, are a characteristic feature of PPGSS. In contrast to patients with EI, patients with parvovirus B19-related PPGSS may remain viremic, and therefore contagious, during the exanthem [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/75\" class=\"abstract_t\">75</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-parvovirus-b19-infection#H525137743\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of parvovirus B19 infection&quot;, section on 'Erythema infectiosum'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acrodermatitis enteropathica </strong>&minus; Acrodermatitis enteropathica is a recessively inherited partial defect in intestinal zinc absorption. The clinical features include hyperpigmented skin lesions on the acral surfaces of the upper and the lower extremities, as well as the face and buttocks (<a href=\"image.htm?imageKey=PEDS%2F71329\" class=\"graphic graphic_picture graphicRef71329 \">picture 10</a>). Acrodermatitis enteropathica is usually associated with other clinical manifestations (eg, alopecia, night blindness, diarrhea, impaired taste, growth retardation, and immune dysfunction) and has a different clinical course from GCS. (See <a href=\"topic.htm?path=zinc-deficiency-and-supplementation-in-children-and-adolescents#H8\" class=\"medical medical_review\">&quot;Zinc deficiency and supplementation in children and adolescents&quot;, section on 'Acrodermatitis enteropathica'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Immunoglobulin A vasculitis (IgAV; Henoch-Sch&ouml;nlein purpura [HSP])</strong> &minus; IgAV (HSP) is the most common form of systemic vasculitis in children. It is characterized by palpable purpura in patients with neither thrombocytopenia nor coagulopathy (<a href=\"image.htm?imageKey=PEDS%2F63367%7EPEDS%2F72094\" class=\"graphic graphic_picture graphicRef63367 graphicRef72094 \">picture 11A-B</a>), <span class=\"nowrap\">arthritis/arthralgia,</span> abdominal pain, and renal disease. The clinical manifestations may develop over the course of days to weeks and may vary in their order of presentation. When present, the noncutaneous manifestations of IgAV (HSP) distinguish it from GCS. (See <a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Kawasaki disease </strong>&minus; Kawasaki disease is another common vasculitis of childhood. It is characterized by systemic inflammation manifested by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, rash, extremity changes, and lymphadenopathy. The mucosal lesions of Kawasaki disease help to distinguish it from GCS. (See <a href=\"topic.htm?path=kawasaki-disease-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Kawasaki disease: Clinical features and diagnosis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The treatment of Gianotti-Crosti syndrome (GCS) is supportive, consisting of symptomatic treatment of pruritus and education of the parents regarding the typically benign clinical course.</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Supportive care</span></p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h3\">Pruritus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptomatic relief for pruritus is the only necessary treatment for most children with GCS. Various treatments for pruritus in GCS have been described in observational studies; none has been studied in a randomized controlled trial.</p><p>In our experience, topical emollients provide adequate relief for most children. We suggest topical <a href=\"topic.htm?path=calamine-lotion-drug-information\" class=\"drug drug_general\">calamine lotion</a> for children with pruritus of moderate severity. We suggest a nocturnal dose of a systemic sedating antihistamine (eg, <a href=\"topic.htm?path=diphenhydramine-drug-information\" class=\"drug drug_general\">diphenhydramine</a>) for children with severe pruritus.</p><p>Topical corticosteroids have been tried in GCS but there is no evidence that the disease course is modified by such therapy [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/44\" class=\"abstract_t\">44</a>]. Nonetheless, they may be helpful in controlling pruritus.</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h3\">Education</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Parents of children with GCS should be provided with information about the etiology, prognosis, complications, and potential spread of the eruption to other children. As a general rule, complications of GCS are rare, the course is benign, and the prognosis is good. (See <a href=\"#H4\" class=\"local\">'Etiology'</a> above and <a href=\"#H14\" class=\"local\">'Course'</a> above and <a href=\"#H26\" class=\"local\">'Control measures'</a> below.)</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h3\">Monitoring</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Children with GCS due to HBV infection should be followed-up regularly. In patients who recover from acute hepatitis B infection without progression to chronic infection, normalization of serum aminotransferases usually occurs within one to four months. Persistent elevation of serum ALT for more than six months indicates chronic hepatitis. (See <a href=\"topic.htm?path=hepatitis-b-virus-clinical-manifestations-and-natural-history#H2\" class=\"medical medical_review\">&quot;Hepatitis B virus: Clinical manifestations and natural history&quot;, section on 'Acute hepatitis'</a>.)</p><p>Children with chronic hepatitis B infection should be referred to a pediatric gastroenterologist or hepatologist. (See <a href=\"#H27\" class=\"local\">'Referral indications'</a> below.)</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h2\">Control measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The likelihood that the eruption will spread to other children depends to some extent upon the underlying etiology. However, for most of the causative infections, children are no longer contagious once the rash appears.</p><p>Exclusion from child-care or school is unnecessary for most children with typical GCS. Children who are hepatitis B surface antigen positive can be admitted to child-care without restrictions provided that they have no behavioral or medical risk factors (eg, aggressive behavior, biting, bleeding disorder) [<a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/86\" class=\"abstract_t\">86</a>].</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h2\">Referral indications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Referral to a pediatric dermatologist may be indicated if the diagnosis is uncertain or the disease course is exceptionally prolonged (eg, longer than six months).</p><p>Referral to a pediatric gastroenterologist or hepatologist is indicated for children with persistently elevated liver enzymes or chronic hepatitis B infection. (See <a href=\"topic.htm?path=overview-of-hepatitis-b-virus-infection-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Overview of hepatitis B virus infection in children and adolescents&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gianotti-Crosti syndrome (GCS) is a symmetric papular eruption with an acral distribution (cheeks, buttocks, and extensor surfaces of the forearms and legs). (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GCS primarily affects children younger than five years, but can occur in adolescents and adults. (See <a href=\"#H3\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>GCS usually occurs in association with a viral illness. Hepatitis B virus (HBV) and Epstein-Barr virus are the most common causes. HBV is an uncommon cause of GCS in the countries where immunization of infants against HBV is routine. (See <a href=\"#H4\" class=\"local\">'Etiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although GCS has been reported to occur after the administration of various vaccines, a causal association has not been established. (See <a href=\"#H8\" class=\"local\">'Vaccines'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of GCS is clinical. The characteristic rash of GCS consists of symmetric monomorphous, flat-topped, pink-brown papules or papulovesicles, 1 to 10 mm in diameter, that occur on the face, buttocks, feet, and extensor aspects of forearms and legs (<a href=\"image.htm?imageKey=PEDS%2F67780%7EDERM%2F95217%7EDERM%2F95218%7EDERM%2F95219%7EDERM%2F95220%7EDERM%2F95221\" class=\"graphic graphic_picture graphicRef67780 graphicRef95217 graphicRef95218 graphicRef95219 graphicRef95220 graphicRef95221 \">picture 1A-F</a>). (See <a href=\"#H10\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noncutaneous findings include malaise, low-grade fever, and diarrhea. Lymphadenopathy is present in 25 to 35 percent of patients, typically in the cervical, axillary, or inguinal regions. Hepatitis, when present, is usually anicteric. (See <a href=\"#H12\" class=\"local\">'Other findings'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An etiologic diagnosis for GCS should be pursued in patients with increased risk for hepatitis B virus infection, immunocompromised patients, and patients who have close contact with immunocompromised individuals or pregnant women. (See <a href=\"#H19\" class=\"local\">'Etiologic diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The constellation of clinical features in GCS is usually characteristic. However, a number of other conditions may warrant consideration early in the course, during resolution, or in atypical cases. These include erythema infectiosum, erythema multiforme, hand-foot-mouth disease, scabies, papular urticaria, lichen planus, papular purpuric gloves and socks syndrome, acrodermatitis enteropathica, immunoglobulin A vasculitis (Henoch-Sch&ouml;nlein purpura), and Kawasaki disease. (See <a href=\"#H20\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The treatment of GCS is supportive. We suggest the following supportive measures (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Topical emollients for mild pruritus</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Topical <a href=\"topic.htm?path=calamine-lotion-drug-information\" class=\"drug drug_general\">calamine lotion</a> for moderate pruritus</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>A nighttime dose of sedating antihistamine (eg, <a href=\"topic.htm?path=diphenhydramine-drug-information\" class=\"drug drug_general\">diphenhydramine</a>) for severe pruritus</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Children with GCS due to HBV infection should be followed-up regularly. (See <a href=\"#H25\" class=\"local\">'Monitoring'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Referral to a pediatric gastroenterologist or hepatologist is indicated for children with persistently elevated liver enzymes or chronic hepatitis B infection. (See <a href=\"#H27\" class=\"local\">'Referral indications'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/1\" class=\"nounderline abstract_t\">GIANOTTI F. [Report on a special case of toxic infection characterized by a desquamative erythemato-infiltrative eruption with lenticular foci and a selective localization at the extremities]. Soc Ital Dermatol Sifilogr Sezioni Interprov Soc Ital Dermatol Sifilogr 1955; 96:678.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/2\" class=\"nounderline abstract_t\">CROSTI A, GIANOTTI F. [Eruptive dermatosis of probable viral origin situated on the acra]. Dermatologica 1957; 115:671.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/3\" class=\"nounderline abstract_t\">Gianotti F. [Viral anicteric hepatitis in infantile papular acrodermatitis]. Epatologia 1966; 12:171.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/4\" class=\"nounderline abstract_t\">Gianotti F. [Infantile papular acrodermatitis. Acrodermatitis papulosa and the infantile papulovesicular acrolocalized syndrome]. Hautarzt 1976; 27:467.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/5\" class=\"nounderline abstract_t\">Gianotti F. Papular acrodermatitis of childhood and other papulo-vesicular acro-located syndromes. Br J Dermatol 1979; 100:49.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/6\" class=\"nounderline abstract_t\">Claudy AL, Ortonne JP, Trepo C, Bugnon B. [Adult papular acrodermatitis (Gianotti's disease). Report of 3 cases]. Ann Dermatol Venereol 1977; 104:190.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/7\" class=\"nounderline abstract_t\">Niitsuma H, Ishii M, Ojima T, et al. [A case of acute hepatitis infected with hepatitis B virus during pregnancy and complicated by Gianotti-Crosti syndrome]. Nihon Shokakibyo Gakkai Zasshi 1999; 96:423.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/8\" class=\"nounderline abstract_t\">Gibbs S, Burrows N. Gianotti-Crosti syndrome in two unrelated adults. Clin Exp Dermatol 2000; 25:594.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/9\" class=\"nounderline abstract_t\">Caputo R, Gelmetti C, Ermacora E, et al. Gianotti-Crosti syndrome: a retrospective analysis of 308 cases. J Am Acad Dermatol 1992; 26:207.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/10\" class=\"nounderline abstract_t\">Brandt O, Abeck D, Gianotti R, Burgdorf W. Gianotti-Crosti syndrome. J Am Acad Dermatol 2006; 54:136.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/11\" class=\"nounderline abstract_t\">Jindal T, Arora VK. Gianotti-crosti syndrome. Indian Pediatr 2000; 37:683.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/12\" class=\"nounderline abstract_t\">Ta&iuml;eb A, Plantin P, Du Pasquier P, et al. Gianotti-Crosti syndrome: a study of 26 cases. Br J Dermatol 1986; 115:49.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/13\" class=\"nounderline abstract_t\">Brown J, Rentiers P. The Gianotti-Crosti syndrome: a distrinctive exanthem. Can Med Assoc J 1969; 100:773.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/14\" class=\"nounderline abstract_t\">Toda G, Ishimaru Y, Mayumi M, Oda T. Infantile papular acrodermatitis (Gianotti's disease) and intrafamilial occurence of acute hepatitis B with jaundice: age dependency of clinical manifestations of hepatitis B virus infection. J Infect Dis 1978; 138:211.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/15\" class=\"nounderline abstract_t\">Ishimaru Y, Ishimaru H, Toda G, et al. An epidemic of infantile papular acrodermatitis (Gianotti's disease) in Japan associated with hepatitis-B surface antigen subtype ayw. Lancet 1976; 1:707.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/16\" class=\"nounderline abstract_t\">Kanzaki S, Kanda S, Terada K, et al. Detection of hepatitis B surface antigen subtype adr in an epidemic of papular acrodermatitis of childhood (Gianotti's disease). Acta Med Okayama 1981; 35:407.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/17\" class=\"nounderline abstract_t\">Baldari U, Monti A, Righini MG. An epidemic of infantile papular acrodermatitis (Gianotti-Crosti syndrome) due to Epstein-Barr virus. Dermatology 1994; 188:203.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/18\" class=\"nounderline abstract_t\">Yoshida M, Tsuda N, Morihata T, et al. Five patients with localized facial eruptions associated with Gianotti-Crosti syndrome caused by primary Epstein-Barr virus infection. J Pediatr 2004; 145:843.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/19\" class=\"nounderline abstract_t\">Demattei C, Zawar V, Lee A, et al. Spatial-temporal case clustering in children with Gianotti-Crosti syndrome. Systematic analysis led to the identification of a mini-epidemic. Eur J Pediat Dermatol 2006; 16:159.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/20\" class=\"nounderline abstract_t\">Chuh A, Zawar V, Sciallis GF, et al. Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? Infect Dis Rep 2016; 8:6418.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/21\" class=\"nounderline abstract_t\">Colombo M, Rumi MG, Sagnelli E, et al. Acute hepatitis B in children with papular acrodermatitis. Pediatr Pathol 1986; 6:249.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/22\" class=\"nounderline abstract_t\">Lee S, Kim KY, Hahn CS, et al. Gianotti-Crosti syndrome associated with hepatitis B surface antigen (subtype adr). J Am Acad Dermatol 1985; 12:629.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/23\" class=\"nounderline abstract_t\">Claudy AL, Ortonne JP, Trepo C, Bugnon B. Papular acrodermatitis associated with hepatitis B virus infection. Arch Dermatol 1979; 115:931.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/24\" class=\"nounderline abstract_t\">Rubenstein D, Esterly NB, Fretzin D. The Gianotti-Crosti syndrome. Pediatrics 1978; 61:433.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/25\" class=\"nounderline abstract_t\">Grigorescu I, Dumitrascu DL. Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection. World J Gastroenterol 2014; 20:15860.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/26\" class=\"nounderline abstract_t\">Smith KJ, Skelton H. Histopathologic features seen in Gianotti-Crosti syndrome secondary to Epstein-Barr virus. J Am Acad Dermatol 2000; 43:1076.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/27\" class=\"nounderline abstract_t\">Maeda S, Tsuda H, Haruki S, Mitsuto I. Atypical Epstein-Barr virus infection associated with Gianotti-Crosti syndrome and Bell's palsy. Pediatr Int 1999; 41:315.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/28\" class=\"nounderline abstract_t\">Drago F, Crovato F, Rebora A. Gianotti-Crosti syndrome as a presenting sign of EBV-induced acute infectious mononucleosis. Clin Exp Dermatol 1997; 22:301.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/29\" class=\"nounderline abstract_t\">Hofmann B, Schuppe HC, Adams O, et al. Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol 1997; 14:273.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/30\" class=\"nounderline abstract_t\">Konno M. [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection]. Hokkaido Igaku Zasshi 1989; 64:125.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/31\" class=\"nounderline abstract_t\">Snelder SM, Engels LK, van der Valk H, van Praag MC. [Skin disorder as an indication of viral infection]. Ned Tijdschr Geneeskd 2015; 159:A8708.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/32\" class=\"nounderline abstract_t\">Hall LD, Eminger LA, Hesterman KS, Heymann WR. Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders. J Am Acad Dermatol 2015; 72:1.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/33\" class=\"nounderline abstract_t\">Al Dhaheri HS, Al Kaabi A, Kara Hamo Y, et al. Unusual Presentation of Gianotti-Crosti Syndrome due to Epstein-Barr Virus Infection. Case Rep Dermatol Med 2016; 2016:1017524.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/34\" class=\"nounderline abstract_t\">Babu TA, Arivazhahan A. Gianotti-Crosti Syndrome following immunization in an 18 months old child. Indian Dermatol Online J 2015; 6:413.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/35\" class=\"nounderline abstract_t\">Stojkovic-Filipovic J, Skiljevic D, Brasanac D, Medenica L. Gianotti-Crosti syndrome associated with Ebstein-Barr virus and Parvovirus B-19 coinfection in a male adult: case report and review of the literature. G Ital Dermatol Venereol 2016; 151:106.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/36\" class=\"nounderline abstract_t\">James WD, Odom RB, Hatch MH. Gianotti-Crosti-like eruption associated with coxsackievirus A-16 infection. J Am Acad Dermatol 1982; 6:862.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/37\" class=\"nounderline abstract_t\">Draelos ZK, Hansen RC, James WD. Gianotti-Crosti syndrome associated with infections other than hepatitis B. JAMA 1986; 256:2386.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/38\" class=\"nounderline abstract_t\">Tzeng GH, Hsu CY, Chen HC. Gianotti-Crosti syndrome associated with cytomegalovirus infection: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1995; 36:139.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/39\" class=\"nounderline abstract_t\">Berant M, Naveh Y, Weissman I. Papular acrodermatitis with cytomegalovirus hepatitis. Arch Dis Child 1983; 58:1024.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/40\" class=\"nounderline abstract_t\">Haki M, Tsuchida M, Kotsuji M, et al. Gianotti-Crosti syndrome associated with cytomegalovirus antigenemia after bone marrow transplantation. Bone Marrow Transplant 1997; 20:691.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/41\" class=\"nounderline abstract_t\">Drago F, Javor S, Ciccarese G, Parodi A. Gianotti-Crosti syndrome as presenting sign of cytomegalovirus infection: A case report and a critical appraisal of its possible cytomegalovirus etiology. J Clin Virol 2016; 78:120.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/42\" class=\"nounderline abstract_t\">Carrascosa JM, Just M, Ribera M, Ferr&aacute;ndiz C. Papular acrodermatitis of childhood related to poxvirus and parvovirus B19 infection. Cutis 1998; 61:265.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/43\" class=\"nounderline abstract_t\">L&eacute;ger F, Callens A, Machet MC. [Parvovirus B19 primo-infection and cold agglutinins]. Ann Dermatol Venereol 1997; 124:257.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/44\" class=\"nounderline abstract_t\">Boeck K, Mempel M, Schmidt T, Abeck D. Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children. Cutis 1998; 62:271.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/45\" class=\"nounderline abstract_t\">Hergueta Lend&iacute;nez R, Pozo Garc&iacute;a L, Alejo Garc&iacute;a A, et al. [Gianotti-Crosti syndrome due to a mixed infection produced by the mumps virus and the parainfluenza virus type 2]. An Esp Pediatr 1996; 44:65.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/46\" class=\"nounderline abstract_t\">Sagi EF, Linder N, Shouval D. Papular acrodermatitis of childhood associated with hepatitis A virus infection. Pediatr Dermatol 1985; 3:31.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/47\" class=\"nounderline abstract_t\">Pouillaude JM, Moulin G, Morlat C, Fran&ccedil;ois R. [Gianotti-Crosti's infantile papular acrodermatitis. Nosological relationship with viral hepatitis. A fatal outcome]. Pediatrie 1975; 30:351.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/48\" class=\"nounderline abstract_t\">Di Lernia V. Gianotti-Crosti syndrome related to rotavirus infection. Pediatr Dermatol 1998; 15:485.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/49\" class=\"nounderline abstract_t\">Di Lernia V, Ricci C. Skin manifestations with Rotavirus infections. Int J Dermatol 2006; 45:759.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/50\" class=\"nounderline abstract_t\">de la Torre C. Gianotti-Crosti syndrome following milkers' nodules. Cutis 2004; 74:316.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/51\" class=\"nounderline abstract_t\">Blauvelt A, Turner ML. Gianotti-Crosti syndrome and human immunodeficiency virus infection. Arch Dermatol 1994; 130:481.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/52\" class=\"nounderline abstract_t\">Yasumoto S, Tsujita J, Imayama S, Hori Y. Case report: Gianotti-Crosti syndrome associated with human herpesvirus-6 infection. J Dermatol 1996; 23:499.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/53\" class=\"nounderline abstract_t\">Chuh AA, Chan HH, Chiu SS, et al. A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections. Pediatr Dermatol 2002; 19:492.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/54\" class=\"nounderline abstract_t\">Terraneo L, Lava SA, Camozzi P, et al. Unusual Eruptions Associated with Mycoplasma pneumoniae Respiratory Infections: Review of the Literature. Dermatology 2015; 231:152.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/55\" class=\"nounderline abstract_t\">Angoulvant N, Gr&eacute;zard P, Wolf F, et al. [Acute Mycoplasma pneumoniae infection: new cause of Gianotti Crosti syndrome]. Presse Med 2000; 29:1287.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/56\" class=\"nounderline abstract_t\">Manoharan S, Muir J, Williamson R. Gianotti-Crosti syndrome in an adult following recent Mycoplasma pneumoniae infection. Australas J Dermatol 2005; 46:106.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/57\" class=\"nounderline abstract_t\">Silveira Cancela M, Vald&eacute;s Tasc&oacute;n F, Pita Carretero J, et al. [Neonatal papular acrodermatitis (Gianotti-Crosti) and Bartonella henselae infection]. An Esp Pediatr 2000; 52:299.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/58\" class=\"nounderline abstract_t\">Baldari U, Cattonar P, Nobile C, et al. Infantile acrodermatitis of Gianotti-Crosti and Lyme borreliosis. Acta Derm Venereol 1996; 76:242.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/59\" class=\"nounderline abstract_t\">Cambiaghi S, Scarabelli G, Pistritto G, Gelmetti C. Gianotti-Crosti syndrome in an adult after influenza virus vaccination. Dermatology 1995; 191:340.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/60\" class=\"nounderline abstract_t\">Kwon NH, Kim JE, Cho BK, Park HJ. Gianotti-Crosti Syndrome Following Novel Influenza A (H1N1) Vaccination. Ann Dermatol 2011; 23:554.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/61\" class=\"nounderline abstract_t\">Lam JM. Atypical Gianotti-Crosti syndrome following administration of the AS03-adjuvanted H1N1 vaccine. J Am Acad Dermatol 2011; 65:e127.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/62\" class=\"nounderline abstract_t\">Kroeskop A, Lewis AB, Barril FA, Baribault KE. Gianotti-Crosti syndrome after H1N1-influenza vaccine. Pediatr Dermatol 2011; 28:595.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/63\" class=\"nounderline abstract_t\">Velangi SS, Tidman MJ. Gianotti-Crosti syndrome after measles, mumps and rubella vaccination. Br J Dermatol 1998; 139:1122.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/64\" class=\"nounderline abstract_t\">Andiran N, Sent&uuml;rk GB, B&uuml;k&uuml;lmez G. Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome. Dermatology 2002; 204:75.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/65\" class=\"nounderline abstract_t\">Karaka&#351; M, Durdu M, Tuncer I, Cevlik F. Gianotti-Crosti syndrome in a child following hepatitis B virus vaccination. J Dermatol 2007; 34:117.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/66\" class=\"nounderline abstract_t\">Erkek E, Senturk GB, Ozkaya O, B&uuml;k&uuml;lmez G. Gianotti-Crosti syndrome preceded by oral polio vaccine and followed by varicella infection. Pediatr Dermatol 2001; 18:516.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/67\" class=\"nounderline abstract_t\">Zawar V, Chuh A. A case-control study on the association of pulse oral poliomyelitis vaccination and Gianotti-Crosti syndrome. Int J Dermatol 2017; 56:75.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/68\" class=\"nounderline abstract_t\">Kolivras A, Andr&eacute; J. Gianotti-Crosti syndrome following hepatitis A vaccination. Pediatr Dermatol 2008; 25:650.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/69\" class=\"nounderline abstract_t\">Kang NG, Oh CW. Gianotti-Crosti syndrome following Japanese encephalitis vaccination. J Korean Med Sci 2003; 18:459.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/70\" class=\"nounderline abstract_t\">Milbradt R, Nasemann T. [Entity of the Gianotti-Crosti's syndrome and its relation to hepatitis B infection]. Hautarzt 1975; 26:471.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/71\" class=\"nounderline abstract_t\">Magyarlaki M, Drobnitsch I, Schneider I. Papular acrodermatitis of childhood (Gianotti-Crosti disease). Pediatr Dermatol 1991; 8:224.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/72\" class=\"nounderline abstract_t\">Ricci G, Patrizi A, Neri I, et al. Gianotti-Crosti syndrome and allergic background. Acta Derm Venereol 2003; 83:202.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/73\" class=\"nounderline abstract_t\">Chuh A, Zawar V, Lee A, Sciallis G. Is Gianotti-Crosti Syndrome Associated with Atopy? A Case-Control Study and a Postulation on the Intrinsic Host Factors in Gianotti-Crosti Syndrome. Pediatr Dermatol 2016; 33:488.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/74\" class=\"nounderline abstract_t\">Pedreira RL, Leal JM, Silvestre KJ, et al. Gianotti-Crosti syndrome: a case report of a teenager. An Bras Dermatol 2016; 91:163.</a></li><li class=\"breakAll\">Paller AS, Mancini AJ. The exanthematous diseases of childhood. In: Hurwitz Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence, 3rd ed, WB Saunders, Philadelphia 2006. p.423.</li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/76\" class=\"nounderline abstract_t\">Chuh AA. Truncal lesions do not exclude a diagnosis of Gianotti-Crosti syndrome. Australas J Dermatol 2003; 44:215.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/77\" class=\"nounderline abstract_t\">Balevicien&eacute; G, Maciulevicien&eacute; R, Schwartz RA. Papular acrodermatitis of childhood: the Gianotti-Crosti syndrome. Cutis 2001; 67:291.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/78\" class=\"nounderline abstract_t\">Tilly JJ, Drolet BA, Esterly NB. Lichenoid eruptions in children. J Am Acad Dermatol 2004; 51:606.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/79\" class=\"nounderline abstract_t\">Sarma N, Sarkar UK, Das MK, Das S. Hemorrhagic Gianotti-Crosti Syndrome in a One and Half Month old Infant: An Extremely Unusual Presentation. Indian J Dermatol 2013; 58:65.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/80\" class=\"nounderline abstract_t\">Spear KL, Winkelmann RK. Gianotti-Crosti syndrome. A review of ten cases not associated with hepatitis B. Arch Dermatol 1984; 120:891.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/81\" class=\"nounderline abstract_t\">Chuh A, Lee A, Zawar V. The diagnostic criteria of Gianotti-Crosti syndrome: are they applicable to children in India? Pediatr Dermatol 2004; 21:542.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/82\" class=\"nounderline abstract_t\">Colombo M, Gerber MA, Vernace SJ, et al. Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterology 1977; 73:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/83\" class=\"nounderline abstract_t\">Patrizi A, Di Lernia V, Neri I, Ricci G. An unusual case of recurrent Gianotti-Crosti syndrome. Pediatr Dermatol 1994; 11:283.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/84\" class=\"nounderline abstract_t\">Gabrielsen TO, Rajka G, Rustenberg B. [Acrodermatitis papulosa eruptiva infantum as a prodrome in hepatitis B infection]. Z Hautkr 1985; 60:1793.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/85\" class=\"nounderline abstract_t\">F&ouml;lster-Holst R, Zawar V, Chuh A. [Paraviral exanthems]. Hautarzt 2017; 68:211.</a></li><li class=\"breakAll\">American Academy of Pediatrics. Hepatitis B. In: Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2009. p.337.</li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/87\" class=\"nounderline abstract_t\">Chuh A, Zawar V, Law M, Sciallis G. Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria. Infect Dis Rep 2012; 4:e12.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/88\" class=\"nounderline abstract_t\">Chuh A, Zawar V, Sciallis GF, Lee A. The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases. J R Coll Physicians Edinb 2015; 45:218.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/89\" class=\"nounderline abstract_t\">Zawar V, Chuh A. Gianotti-crosti syndrome in India is not associated with hepatitis B infection. Dermatology 2004; 208:87.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/90\" class=\"nounderline abstract_t\">Nelson JS, Stone MS. Update on selected viral exanthems. Curr Opin Pediatr 2000; 12:359.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/91\" class=\"nounderline abstract_t\">Stone MS, Murph JR. Papular-purpuric gloves and socks syndrome: a characteristic viral exanthem. Pediatrics 1993; 92:864.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/92\" class=\"nounderline abstract_t\">Harms M, Feldmann R, Saurat JH. Papular-purpuric &quot;gloves and socks&quot; syndrome. J Am Acad Dermatol 1990; 23:850.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/93\" class=\"nounderline abstract_t\">Hsieh MY, Huang PH. The juvenile variant of papular-purpuric gloves and socks syndrome and its association with viral infections. Br J Dermatol 2004; 151:201.</a></li><li><a href=\"https://www.uptodate.com/contents/gianotti-crosti-syndrome-papular-acrodermatitis/abstract/94\" class=\"nounderline abstract_t\">Grilli R, Izquierdo MJ, Fari&ntilde;a MC, et al. Papular-purpuric &quot;gloves and socks&quot; syndrome: polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol 1999; 41:793.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 4040 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H28\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">TERMINOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">ETIOLOGY</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Hepatitis B virus</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Epstein-Barr virus</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Other infections</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Vaccines</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">PATHOGENESIS</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">CLINICAL FEATURES</a><ul><li><a href=\"#H11\" id=\"outline-link-H11\">Dermatologic findings</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Other findings</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Laboratory findings</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Course</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">- Complications</a></li></ul></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">DIAGNOSIS</a><ul><li><a href=\"#H17\" id=\"outline-link-H17\">Clinical diagnosis</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">Skin biopsy</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Etiologic diagnosis</a><ul><li><a href=\"#H26396446\" id=\"outline-link-H26396446\">- HBV</a></li><li><a href=\"#H26396461\" id=\"outline-link-H26396461\">- Other viruses</a></li></ul></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">TREATMENT</a><ul><li><a href=\"#H22\" id=\"outline-link-H22\">Supportive care</a><ul><li><a href=\"#H23\" id=\"outline-link-H23\">- Pruritus</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">- Education</a></li><li><a href=\"#H25\" id=\"outline-link-H25\">- Monitoring</a></li></ul></li><li><a href=\"#H26\" id=\"outline-link-H26\">Control measures</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">Referral indications</a></li></ul></li><li><a href=\"#H28\" id=\"outline-link-H28\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/4040|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/67780\" class=\"graphic graphic_picture\">- Gianotti-Crosti syndrome extremity</a></li><li><a href=\"image.htm?imageKey=DERM/95217\" class=\"graphic graphic_picture\">- Gianotti-Crosti syndrome papulovesicles</a></li><li><a href=\"image.htm?imageKey=DERM/95218\" class=\"graphic graphic_picture\">- Gianotti-Crosti syndrome face</a></li><li><a href=\"image.htm?imageKey=DERM/95219\" class=\"graphic graphic_picture\">- Gianotti-Crosti syndrome eruption</a></li><li><a href=\"image.htm?imageKey=DERM/95220\" class=\"graphic graphic_picture\">- Gianotti-Crosti syndrome on extremity</a></li><li><a href=\"image.htm?imageKey=DERM/95221\" class=\"graphic graphic_picture\">- Gianotti-Crosti syndrome buttocks</a></li><li><a href=\"image.htm?imageKey=PEDS/71737\" class=\"graphic graphic_picture\">- Slapped cheek rash</a></li><li><a href=\"image.htm?imageKey=ID/75125\" class=\"graphic graphic_picture\">- Rash in erythema infectiosum</a></li><li><a href=\"image.htm?imageKey=ID/74095\" class=\"graphic graphic_picture\">- Erythema multiforme</a></li><li><a href=\"image.htm?imageKey=DERM/58566\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - buccal</a></li><li><a href=\"image.htm?imageKey=DERM/71314\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - tongue</a></li><li><a href=\"image.htm?imageKey=DERM/53423\" class=\"graphic graphic_picture\">- Hand-foot-and-mouth disease - foot</a></li><li><a href=\"image.htm?imageKey=DERM/56862\" class=\"graphic graphic_picture\">- Scabies infant foot 2</a></li><li><a href=\"image.htm?imageKey=DERM/54315\" class=\"graphic graphic_picture\">- Scabies wrist infant</a></li><li><a href=\"image.htm?imageKey=PC/59807\" class=\"graphic graphic_picture\">- Lichen planus</a></li><li><a href=\"image.htm?imageKey=PC/50579\" class=\"graphic graphic_picture\">- Lichen planus wrist</a></li><li><a href=\"image.htm?imageKey=ID/51856\" class=\"graphic graphic_picture\">- Gloves and socks syndrome</a></li><li><a href=\"image.htm?imageKey=PEDS/71329\" class=\"graphic graphic_picture\">- Acrodermatitis enteropathica</a></li><li><a href=\"image.htm?imageKey=PEDS/63367\" class=\"graphic graphic_picture\">- Rash - Henoch-Schonlein purpura (IgA vasculitis)</a></li><li><a href=\"image.htm?imageKey=PEDS/72094\" class=\"graphic graphic_picture\">- Rash - Henoch Schonlein purpura IgA vasculitis B</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-parvovirus-b19-infection\" class=\"medical medical_review\">Clinical manifestations and diagnosis of parvovirus B19 infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-treatment-of-epstein-barr-virus-infection\" class=\"medical medical_review\">Clinical manifestations and treatment of Epstein-Barr virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-eruptions\" class=\"medical medical_review\">Drug eruptions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-transmission-and-prevention-of-hepatitis-b-virus-infection\" class=\"medical medical_review\">Epidemiology, transmission, and prevention of hepatitis B virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hand-foot-and-mouth-disease-and-herpangina\" class=\"medical medical_review\">Hand, foot, and mouth disease and herpangina</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-b-virus-clinical-manifestations-and-natural-history\" class=\"medical medical_review\">Hepatitis B virus: Clinical manifestations and natural history</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-b-virus-screening-and-diagnosis\" class=\"medical medical_review\">Hepatitis B virus: Screening and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=iga-vasculitis-henoch-schonlein-purpura-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">IgA vasculitis (Henoch-Sch&ouml;nlein purpura): Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=insect-bites\" class=\"medical medical_review\">Insect bites</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=kawasaki-disease-clinical-features-and-diagnosis\" class=\"medical medical_review\">Kawasaki disease: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lichen-planus\" class=\"medical medical_review\">Lichen planus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-hepatitis-b-virus-infection-in-children-and-adolescents\" class=\"medical medical_review\">Overview of hepatitis B virus infection in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=scabies-epidemiology-clinical-features-and-diagnosis\" class=\"medical medical_review\">Scabies: Epidemiology, clinical features, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-relationship-between-ige-and-allergic-disease\" class=\"medical medical_review\">The relationship between IgE and allergic disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zinc-deficiency-and-supplementation-in-children-and-adolescents\" class=\"medical medical_review\">Zinc deficiency and supplementation in children and adolescents</a></li></ul></div></div>","javascript":null}